药石科技
(300725)
| 流通市值：68.42亿 | | | 总市值：78.91亿 |
| 流通股本：2.03亿 | | | 总股本：2.34亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 508,031,084.22 | 1,974,477,816.91 | 1,419,054,885.82 | 919,729,079.06 |
| 营业收入 | 508,031,084.22 | 1,974,477,816.91 | 1,419,054,885.82 | 919,729,079.06 |
| 二、营业总成本 | 456,125,396.67 | 1,773,858,616.58 | 1,281,579,226.63 | 829,705,605.73 |
| 营业成本 | 344,742,095.37 | 1,366,023,396.27 | 979,876,477.06 | 634,187,513.17 |
| 税金及附加 | 5,110,158.66 | 24,693,603 | 18,500,941.28 | 11,317,519.75 |
| 销售费用 | 19,957,254.62 | 66,809,363.32 | 46,561,981.64 | 30,891,836 |
| 管理费用 | 45,873,521.5 | 175,752,832.63 | 131,963,054.07 | 86,287,364.87 |
| 研发费用 | 29,809,579.94 | 108,717,103.68 | 79,045,014.56 | 48,352,749.39 |
| 财务费用 | 10,632,786.58 | 31,862,317.68 | 25,631,758.02 | 18,668,622.55 |
| 其中:利息费用 | 618,477.49 | 34,218,915.44 | 36,518,069.43 | 26,659,424.42 |
| 其中:利息收入 | 2,029,939.51 | 6,847,133.41 | 9,857,791.51 | 8,306,009.58 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,730,020.7 | 678,192.97 | 1,886,235.72 | -434,704.1 |
| 加:投资收益 | 6,282,135.75 | 36,281,193.53 | 21,642,740.8 | 11,059,877.09 |
| 资产处置收益 | - | 1,148,940.44 | - | - |
| 资产减值损失(新) | -10,765,562.44 | -30,593,044.68 | -52,886,799.16 | -35,171,242.71 |
| 信用减值损失(新) | -2,479,310.56 | -19,789,231.07 | 6,017,450.03 | 10,199,575.32 |
| 其他收益 | 6,516,289.86 | 22,137,921.56 | 16,262,839.51 | 11,692,255.91 |
| 四、营业利润 | 53,189,260.86 | 210,483,173.08 | 130,398,126.09 | 87,369,234.84 |
| 加:营业外收入 | 18,200 | 419,519.51 | 433,649.28 | 186,690.63 |
| 减:营业外支出 | 410,984.1 | 3,293,565.73 | 2,597,611.53 | 1,284,663.14 |
| 五、利润总额 | 52,796,476.76 | 207,609,126.86 | 128,234,163.84 | 86,271,262.33 |
| 减:所得税费用 | 3,909,872.77 | 23,873,612.47 | 14,843,532.57 | 13,773,163.21 |
| 六、净利润 | 48,886,603.99 | 183,735,514.39 | 113,390,631.27 | 72,498,099.12 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 48,886,603.99 | 183,735,514.39 | 113,390,631.27 | 72,498,099.12 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 48,886,603.99 | 183,735,514.39 | 113,390,631.27 | 72,498,099.12 |
| 扣除非经常损益后的净利润 | 38,753,660.47 | 145,002,880.08 | 88,157,340.26 | 59,621,052.27 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.88 | 0.56 | 0.36 |
| (二)稀释每股收益 | 0.21 | 0.88 | 0.56 | 0.36 |
| 八、其他综合收益 | -850,648,440.33 | 2,034,625,850.9 | 2,945,282,499.54 | 620,307,975.98 |
| 归属于母公司股东的其他综合收益 | -850,648,440.33 | 2,034,625,850.9 | 2,945,282,499.54 | 620,307,975.98 |
| 九、综合收益总额 | -801,761,836.34 | 2,218,361,365.29 | 3,058,673,130.81 | 692,806,075.1 |
| 归属于母公司股东的综合收益总额 | -801,761,836.34 | 2,218,361,365.29 | 3,058,673,130.81 | 692,806,075.1 |
| 公告日期 | 2026-04-22 | 2026-04-22 | 2025-10-30 | 2025-08-08 |
| 审计意见(境内) | | 标准无保留意见 | | |